127 related articles for article (PubMed ID: 33895538)
1. Task matters - challenging the motor system allows distinguishing unaffected Parkin mutation carriers from mutation-free controls.
Prasuhn J; Borsche M; Hicks AA; Gögele M; Egger C; Kritzinger C; Pichler I; Castelo-Rueda MP; Langlott L; Kasten M; Mascalzoni D; Klein C; Pramstaller PP; Brüggemann N
Parkinsonism Relat Disord; 2021 May; 86():101-104. PubMed ID: 33895538
[TBL] [Abstract][Full Text] [Related]
2. Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.
Malek N; Swallow DM; Grosset KA; Lawton MA; Smith CR; Bajaj NP; Barker RA; Ben-Shlomo Y; Bresner C; Burn DJ; Foltynie T; Morris HR; Williams N; Wood NW; Grosset DG;
Acta Neurol Scand; 2016 Oct; 134(4):271-6. PubMed ID: 26626018
[TBL] [Abstract][Full Text] [Related]
3. Substantia nigra hyperechogenicity correlates with clinical status and number of Parkin mutated alleles.
Hagenah JM; König IR; Becker B; Hilker R; Kasten M; Hedrich K; Pramstaller PP; Klein C; Seidel G
J Neurol; 2007 Oct; 254(10):1407-13. PubMed ID: 17934880
[TBL] [Abstract][Full Text] [Related]
4. Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.
Chien HF; Rohé CF; Costa MD; Breedveld GJ; Oostra BA; Barbosa ER; Bonifati V
Neurogenetics; 2006 Mar; 7(1):13-9. PubMed ID: 16328510
[TBL] [Abstract][Full Text] [Related]
5. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.
Pramstaller PP; Schlossmacher MG; Jacques TS; Scaravilli F; Eskelson C; Pepivani I; Hedrich K; Adel S; Gonzales-McNeal M; Hilker R; Kramer PL; Klein C
Ann Neurol; 2005 Sep; 58(3):411-22. PubMed ID: 16130111
[TBL] [Abstract][Full Text] [Related]
6. Frequency of heterozygous Parkin mutations in healthy subjects: need for careful prospective follow-up examination of mutation carriers.
Brüggemann N; Mitterer M; Lanthaler AJ; Djarmati A; Hagenah J; Wiegers K; Winkler S; Pawlack H; Lohnau T; Pramstaller PP; Klein C; Lohmann K
Parkinsonism Relat Disord; 2009 Jul; 15(6):425-9. PubMed ID: 19162522
[TBL] [Abstract][Full Text] [Related]
7. Influence of L-dopa on subtle motor signs in heterozygous Parkin- and PINK1 mutation carriers.
Weissbach A; König IR; Hückelheim K; Pramstaller PP; Werner E; Brüggemann N; Tadic V; Lohmann K; Bäumer T; Münchau A; Kasten M; Klein C
Parkinsonism Relat Disord; 2017 Sep; 42():95-99. PubMed ID: 28716427
[TBL] [Abstract][Full Text] [Related]
8. Clinical and brain imaging characteristics in leucine-rich repeat kinase 2-associated PD and asymptomatic mutation carriers.
Brockmann K; Gröger A; Di Santo A; Liepelt I; Schulte C; Klose U; Maetzler W; Hauser AK; Hilker R; Gomez-Mancilla B; Berg D; Gasser T
Mov Disord; 2011 Nov; 26(13):2335-42. PubMed ID: 21989859
[TBL] [Abstract][Full Text] [Related]
9. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.
Marder KS; Tang MX; Mejia-Santana H; Rosado L; Louis ED; Comella CL; Colcher A; Siderowf AD; Jennings D; Nance MA; Bressman S; Scott WK; Tanner CM; Mickel SF; Andrews HF; Waters C; Fahn S; Ross BM; Cote LJ; Frucht S; Ford B; Alcalay RN; Rezak M; Novak K; Friedman JH; Pfeiffer RF; Marsh L; Hiner B; Neils GD; Verbitsky M; Kisselev S; Caccappolo E; Ottman R; Clark LN
Arch Neurol; 2010 Jun; 67(6):731-8. PubMed ID: 20558392
[TBL] [Abstract][Full Text] [Related]
10. Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach.
van Nuenen BF; van Eimeren T; van der Vegt JP; Buhmann C; Klein C; Bloem BR; Siebner HR
Mov Disord; 2009; 24 Suppl 2():S703-10. PubMed ID: 19877238
[TBL] [Abstract][Full Text] [Related]
11. Responsiveness to distracting stimuli, though increased in Parkinson's disease, is decreased in asymptomatic PINK1 and Parkin mutation carriers.
Verleger R; Hagenah J; Weiss M; Ewers T; Heberlein I; Pramstaller PP; Siebner HR; Klein C
Neuropsychologia; 2010 Jan; 48(2):467-76. PubMed ID: 19822161
[TBL] [Abstract][Full Text] [Related]
12. A multidisciplinary study of patients with early-onset PD with and without parkin mutations.
Lohmann E; Thobois S; Lesage S; Broussolle E; du Montcel ST; Ribeiro MJ; Remy P; Pelissolo A; Dubois B; Mallet L; Pollak P; Agid Y; Brice A;
Neurology; 2009 Jan; 72(2):110-6. PubMed ID: 18987353
[TBL] [Abstract][Full Text] [Related]
13. Machine learning-based motor assessment of Parkinson's disease using postural sway, gait and lifestyle features on crowdsourced smartphone data.
Abujrida H; Agu E; Pahlavan K
Biomed Phys Eng Express; 2020 Mar; 6(3):035005. PubMed ID: 33438650
[TBL] [Abstract][Full Text] [Related]
14. Case-control study of the parkin gene in early-onset Parkinson disease.
Clark LN; Afridi S; Karlins E; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Arch Neurol; 2006 Apr; 63(4):548-52. PubMed ID: 16606767
[TBL] [Abstract][Full Text] [Related]
15. Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk.
Lubbe SJ; Bustos BI; Hu J; Krainc D; Joseph T; Hehir J; Tan M; Zhang W; Escott-Price V; Williams NM; Blauwendraat C; Singleton AB; Morris HR;
Hum Mol Genet; 2021 Mar; 30(1):78-86. PubMed ID: 33448283
[TBL] [Abstract][Full Text] [Related]
16. High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry.
Pyatigorskaya N; Sharman M; Corvol JC; Valabregue R; Yahia-Cherif L; Poupon F; Cormier-Dequaire F; Siebner H; Klebe S; Vidailhet M; Brice A; Lehéricy S
Mov Disord; 2015 Jul; 30(8):1077-84. PubMed ID: 26011561
[TBL] [Abstract][Full Text] [Related]
17. Event-related potential changes due to early-onset Parkinson's disease in parkin (PARK2) gene mutation carriers and non-carriers.
Uslu A; Ergen M; Demirci H; Lohmann E; Hanagasi H; Demiralp T
Clin Neurophysiol; 2020 Jul; 131(7):1444-1452. PubMed ID: 32388155
[TBL] [Abstract][Full Text] [Related]
18. Compensatory premotor activity during affective face processing in subclinical carriers of a single mutant Parkin allele.
Anders S; Sack B; Pohl A; Münte T; Pramstaller P; Klein C; Binkofski F
Brain; 2012 Apr; 135(Pt 4):1128-40. PubMed ID: 22434215
[TBL] [Abstract][Full Text] [Related]
19. Abnormal premotor-motor interaction in heterozygous Parkin- and Pink1 mutation carriers.
Weissbach A; Bäumer T; Pramstaller PP; Brüggemann N; Tadic V; Chen R; Klein C; Münchau A
Clin Neurophysiol; 2017 Jan; 128(1):275-280. PubMed ID: 27843055
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial impairment observed in fibroblasts from South African Parkinson's disease patients with parkin mutations.
van der Merwe C; Loos B; Swart C; Kinnear C; Henning F; van der Merwe L; Pillay K; Muller N; Zaharie D; Engelbrecht L; Carr J; Bardien S
Biochem Biophys Res Commun; 2014 May; 447(2):334-40. PubMed ID: 24721425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
